In line with these possibilities, histone deacetylase (HDAC) inhibitors, modifying the post-transcriptional epigenetic, enhanced IR-induced NKG2D ligand expression and increased susceptibility of tumor cells to NK cells. The gene discussed is KLRK1; the disease is neoplasm.